Pricing Matters

The information in this section of the PBS website relates to the ex-manufacturer prices of brands of pharmaceutical item subsidised under the PBS.  It is intended to provide guidance on the processes used to agree and review ex-manufacturer prices for pharmaceutical benefits, including on statutory price reductions applied under Division 3A of the National Health Act 1953.

Information on the mark-ups and fees that apply to pharmaceutical benefits when they are supplied in different settings (eg. community pharmacy, public hospital, private hospital) or under different PBS programs (eg. general schedule, Section 100 Highly Specialised Drugs Program, Section 100 Efficient Funding of Chemotherapy) is available in the Explanation of PBS Pricing.

New processes and supporting cost recovery arrangements apply. Please refer to the PBS Process Improvements and Cost Recovery pages for more information.

General Pricing Information

Contacts

For queries related to PBS pricing please email the Department through the Pricing Section.


Last updated
30 June 2023